NanoBio, U-M Nab $1.5M to Treat Combat Injuries

Xconomy Detroit/Ann Arbor — 

NanoBio, the Ann Arbor, MI-based company developing nanotech formulations of drugs and vaccines, said today it has been awarded a $1.5 million federal research grant along with the University of Michigan to study how to prevent burn wounds on the battlefield from getting dangerously infected. The grant, from the U.S. Department of Defense, will be used for experiments to pave the way for clinical trials of NB-201, a topical anti-infective treatment designed to reduce the severity of infections in burn wounds and inflammation after a burn injury, the company said in a statement.